Current Awareness
Free Access
Current literature in diabetes
First published: 20 May 2010
Abstract
In order to keep subscribers up-to-date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of diabetes/metabolism. Each bibliography is divided into 26 sections: 1 Reviews; 2 General; 3 Genetics; 4 Epidemiology; 5 Immunology; 6 Obesity; 7 Prediction and Prevention; 8 Intervention: a) General; b) Care; c) Drug Therapy; d)Economics; e) Gene therapy; f) Nursing; g) Nutrition; h) Surgery; i) Transplantation; 9 Pathology and Complications: a) General; b) Cardiovascular; c) Eye disease; d) Gestational and fetal; e) Neurological; f) Podiatrical; g) Renal; 10 Endocrinology & Metabolism; 11 Experimental Studies; 12 Diagnosis and Techniques. Within each section, articles are listed in alphabetical order with respect to author
Current Awareness
- 1. Reviews
- Special issue: DAWN Youth: International insights and strategies toward a person-centred care model for young people with diabetes. Pediatr Diabetes (2009) 10:
- Ali MK, Narayan KMV, Mohan V. Innovative research for equitable diabetes care in India. Diabetes Res Clin Pract (2009) 86: 155
- Anselmino M. Cardiovascular prevention in type 2 diabetes mellitus patients: The role of oral glucose-lowering agents. J Diabetes Complications (2009) 23: 427
- Bowling FL, Jude EB, Boulton AJM. MRSA and diabetic foot wounds: Contaminating or infecting organisms?. Curr Diab Rep (2009) 9: 440
- Cerbone AM, Macarone-Palmieri N, Saldalamacchia G, Coppola A, Minno G, Rivellese AA. Diabetes, vascular complications and antiplatelet therapy: Open problems. Acta Diabetol (2009) 46: 253
- Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P, Little R, Schloot NC, Leslie RD, Skyler JS, Palmer JP. Challenges in developing endpoints for type 1 diabetes intervention studies. Diabetes Metab Res Rev (2009) 25: 694
- Concha JB, Kravitz HM, Chin MH, Kelley MA, Chavez N, Johnson TP. Review of type 2 diabetes management interventions for addressing emotional well-being in latinos. Diabetes Educ (2009) 35: 941
- Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of type 2 diabetes mellitus and emerging treatment strategies. Diabet Med (2009) 26: 1185
- Draznin B. Mitogenic action of insulin: Friend, foe or ‘frenemy’?. Diabetologia (2010) 53: 229
- Foley RN, Collins AJ. The growing economic burden of diabetic kidney disease. Curr Diab Rep (2009) 9: 460
- Freeman R. Not all neuropathy in diabetes is of diabetic etiology: Differential diagnosis of diabetic neuropathy. Curr Diab Rep (2009) 9: 423
- Gloyn AL. RD Lawrence Lecture 2009. Old genes, new tricks: Learning about blood glucose regulation from naturally occurring genetic variation in humans. Diabet Med (2009) 26: 1083
- Kakleas K, Kandyla B, Karayianni C, Karavanaki K. Psychosocial problems in adolescents with type 1 diabetes mellitus. Diabetes Metab (2009) 35: 339
- Kang YS, Cha DR. Aldosterone and diabetic kidney disease. Curr Diab Rep (2009) 9: 453
- Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia (2010) 53: 10
- Komers R. What is the role of renin inhibition in the treatment of diabetic kidney disease?. Curr Diab Rep (2009) 9: 447
- Ling C, Groop L. Epigenetics: A molecular link between environmental factors and type 2 diabetes. Diabetes (2009) 58: 2718
- Matthaei S, Bierwirth R, Fritsche A, Gallwitz B, Haring HU, Joost HG, Kellerer M, Kloos C, Kunt T, Nauck M, Schernthaner G, Siegel E, Thienel F. Medical antihyperglycaemic treatment of type 2 diabetes mellitus. Update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes (2009) 117: 522
- Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Al Fogelman A. HDL as a biomarker, potential therapeutic target, and therapy. Diabetes (2009) 58: 2711
- Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP. Diabetes in Japan: A review of disease burden and approaches to treatment. Diabetes Metab Res Rev (2009) 25: 705
- Praet SFE, Van Loon LJC. Exercise therapy in type 2 diabetes. Acta Diabetol (2009) 46: 263
- Rathcke CN, Vestergaard H. YKL-40—an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol (2009) 8: 61
- Sosenko JM. The prevalence of diabetic neuropathy according to ethnicity. Curr Diab Rep (2009) 9: 435
- Steinke JM. The natural progression of kidney injury in young type 1 diabetic patients. Curr Diab Rep (2009) 9: 473
- Tesfaye S, Selvarajah D. The Eurodiab study: What has this taught us about diabetic peripheral neuropathy?. Curr Diab Rep (2009) 9: 432
- Verges B. Lipid disorders in type 1 diabetes. Diabetes Metab (2009) 35: 353
- Williams ME. Management of diabetes in dialysis patients. Curr Diab Rep (2009) 9: 466
- Wukich DK, Sung WJ. Charcot arthropathy of the foot and ankle: Modern concepts and management review. J Diabetes Complications (2009) 23: 409
- 3. Genetics
- Asano H, Izawa H, Nagata K, Nakatochi M, Kobayashi M, Hirashiki A, Shintani S, Nishizawa T, Tanimura D, Naruse K, Matsubara T, Murohara T, Yokota M. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia (2010) 53: 234
- Beijers HJBH, Losekoot M, Odink RJ, Bravenboer B. Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young. Diabet Med (2009) 26: 1172
- Craig DW, Millis MP, DiStefano JK. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to type 1 diabetes. Diabet Med (2009) 26: 1090
- Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Diabetes Metab Res Rev (2009) 25: 717
- Feng RN, Li Y, Zhao D, Wang C, Niu YC, Sun CH. Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: A meta-analysis. Acta Diabetol (2009) 46: 339
- Hovnik T, Dolzan V, Bratina NU, Podkrajsek KT, Battelino T. Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care (2009) 32: 2258
- Hu C, Wang C, Zhang R, Ng MC, Bao Y, Wang C, So WY, Ma RC, Ma X, Chan JC, Xiang K, Jia W. Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population. Diabetologia (2010) 53: 290
- Jermendy A, Szatmari I, Laine AP, Lukacs K, Horvath KH, Korner A, Madacsy L, Veijola R, Simell O, Knip M, Ilonen J, Hermann R. The interferon-induced helicase IFIH1 Ala946Thr polymorphism is associated with type 1 diabetes in both the high-incidence Finnish and the medium-incidence Hungarian populations. Diabetologia (2010) 53: 98
- Kawai T, Ng MCY, Hayes MG, Yoshiuchi I, Tsuchiya T, Robertson H, Cox NJ, Polonsky KS, Bell GI, Ehrmann DA. Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome. Diabetes Res Clin Pract (2009) 86: 186
- Kelliny C, Ekelund U, Andersen LB, Brage S, Loos RJF, Wareham NJ, Langenberg C. Common genetic determinants of glucose homeostasis in healthy children: The European Youth Heart Study. Diabetes (2009) 58: 2939
- Li X, Shu YH, Xiang AH, Trigo E, Kuusisto J, Hartiala J, Swift AJ, Kawakubo M, Stringham HM, Bonnycastle LL, Lawrence JM, Laakso M, Allayee H, Buchanan TA, Watanabe RM. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose. Diabetes (2009) 58: 2946
- Liu QC, Zhuang ZH, Zeng K, Cheng ZJ, Gao F, Wang ZQ. Prevalence of pancreatic diabetes in patients carrying mutations or polymorphisms of the PRSS1 gene in the Han population. Diabetes Technol Ther (2009) 11: 799
- Malhotra A, Igo RP, Thameen F, Kao WHL, Abboud HE, Adler SG, Arar NH, Bowden DW, Duggirala R, Freedman BI, Goddard KA, Ipp E, Iyengar SK, Kimmel PL, Knowler WC, Kohn O, Leehey D, Meoni LA, Nelson RG, Nicholas SB, Parekh RS, Rich SS, Chen YD, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Taylor KD, Thornley-Brown D, Zager PG, Horvath A, Hanson RL. Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations - Significant evidence for linkage on chromosome 4q in African Americans: The Family Investigation of Nephropathy and Diabetes Research Group. Diabetes Metab Res Rev (2009) 25: 740
- Muntinghe FLH, Gross S, Bakker SJL, Landman GWD, Van der Harst P, Bilo HJG, Navis G, Zuurman MW. CCR5Δ32 genotype is associated with outcome in type 2 diabetes mellitus. Diabetes Res Clin Pract (2009) 86: 140
- Naj AC, Kao WHL, O'Connell JR, Mitchell BD, Silver KD. Sequence variation in IGF1R is associated with differences in insulin levels in nondiabetic Old Order Amish. Diabetes Metab Res Rev (2009) 25: 773
- Odem J, Munzinger E, Violand S, Van Morlan A, Rife D, Bachrach B. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age. Pediatr Diabetes (2009) 10: 550
- Palmer ND, Langefeld CD, Ziegler JT, Hsu F, Haffner SM, Fingerlin T, Norris JM, Chen YI, Rich SS, Haritunians T, Taylor KD, Bergman RN, Rotter JI, Bowden DW. Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study. Diabetologia (2010) 53: 281
- Reiling E, Jafar-Mohammadi B, Van't Riet E, Weedon MN, Van Vliet-Ostaptchouk JV, Hansen T, Saxena R, Van Haeften TW, Arp PA, Das S, Nijpels G, Groenewoud MJ, Van Hove EC, Uitterlinden AG, Smit JW, Morris AD, Doney AS, Palmer CN, Guiducci C, Hattersley AT, Frayling TM, Pedersen O, Slagboom PE, Altshuler DM, Groop L, Romijn JA, Maassen JA, Hofker MH, Dekker JM, McCarthy MI, 'T Hart LM. Genetic association analysis of LARS2 with type 2 diabetes. Diabetologia (2010) 53: 103
- Rubio-Cabezas O. Diagnosing monogenic diabetes: Common misinterpretations of genetic findings. Pediatr Diabetes (2009) 10: 497
- Ruchat SM, Weisnagel SJ, Vohl MC, Rankinen T, Bouchard C, Perusse L. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects. Exp Clin Endocrinol Diabetes (2009) 117: 455
- Schneider JG, Schiekofer S, Von Eynatten M, Schlimmer P, Dugi KA. The proline 12 alanine substitution in the PPARγ2 gene is associated with increased extent of coronary artery disease in men. Exp Clin Endocrinol Diabetes (2009) 117: 519
- Suliman SGL, Stanik J, McCulloch LJ, Wilson N, Edghill EL, Misovicova N, Gasperikova D, Sandrikova V, Eliott KS, Barak L, Ellard S, Volpi EV, Klimes I, Gloyn AL. Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: New insights into synergistic pathways involved in growth and metabolism. Diabetes (2009) 58: 2954
- Szopa M, Malczewska-Malec M, Wilk B, Skupien J, Wolkow P, Malecki MT, Sieradzki J. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol (2009) 46: 317
- Taghavi SM, Fatemi SS, Rafatpanah H, Ganjali R, Tavakolafshari J, Valizadeh N. Mutations in the coding regions of the hepatocyte nuclear factor 4 α in Iranian families with maturity onset diabetes of the young. Cardiovasc Diabetol (2009) 8: 63
- Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, Serizawa M, Fujisawa T, Nakashima E, Ohnaka K, Ikegami H, Sugiyama T, Nabika T, Kasturiratne A, Yamaguchi S, Kono S, Takayanagi R, Yamori Y, Kobayashi S, Ogihara T, De Silva A, Wickremasinghe R, Kato N. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia (2010) 53: 299
- Yuasa S, Maruyama Y, Hirose H, Kawai T, Matsunaga-Irie S, Itoh H. MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes. Diabetes Res Clin Pract (2009) 86: 193
- Zhu SY, Liu Y, Wang X, Wu XP, Zhu XL, Li JY, Ma J, Gu HF, Liu Y. Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population. Diabetes Res Clin Pract (2009) 86: 168
- Zillikens MC, Van Meurs JBJ, Rivadaneira F, Amin N, Hofman A, Oostra BA, Sijbrands EJG, Wittentan JCM, Pols HAP, Van Duijn CM, Uitterlinden AG. SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes (2009) 58: 2828
- 4. Epidemiology
- Algert CS, McElduff A, Morris JM, Roberts CL. Perinatal risk factors for early onset of type 1 diabetes in a 2000-2005 birth cohort. Diabet Med (2009) 26: 1193
- Barr ELM, Cameron AJ, Balkau B, Zimmet PZ, Welborn TA, Tonkin AM, Shaw JE. HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study. Diabetologia (2010) 53: 79
- Beard HA, Al Ghatrif M, Samper-Ternent R, Gerst K, Markides KS. Trends in diabetes prevalence and diabetes-related complications in older Mexican Americans from 1993-1994 to 2004-2005. Diabetes Care (2009) 32: 2212
- Bethel MA, Deedwania P, Levitt NS, Schmitz O, Huntsman-Labed A, Califf RM, Haffner SM, Diem P. Metabolic syndrome and alanine aminotransferase: A global perspective from the NAVIGATOR screening population. Diabet Med (2009) 26: 1204
- Emanuele N, Moritz T, Klein R, Davis MD, Glander K, Khanna A, Thottapurathu L, Bahn G, Duckworth W, Abraira C. Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT). Diabetes Res Clin Pract (2009) 86: 104
- Gao WG, Dong YH, Pang ZC, Nan HR, Zhang L, Wang SJ, Ren J, Ning F, Qiao Q. Increasing trend in the prevalence of type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China. Diabet Med (2009) 26: 1220
- Gautier A, Balkau B, Lange C, Tichet J, Bonnet F. Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: The role of γ-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetologia (2010) 53: 247
- Gucciardi E, Vogt JA, DeMelo M, Stewart DE. Exploration of the relationship between household food insecurity and diabetes in Canada. Diabetes Care (2009) 32: 2218
- Heraclides A, Chandola T, Witte DR, Brunner EJ. Psychosocial stress at work doubles the risk of type 2 diabetes in middle-aged women: Evidence from the Whitehall II study. Diabetes Care (2009) 32: 2230
- Hermans MP, Ahn SA, Selvais PL, Rousseau MF. Handedness, insulin sensitivity and pancreatic B-cell function in type 2 diabetes. Diabet Med (2009) 26: 1289
- Janghorbani M, Amini M. Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran. Diabetes Metab Res Rev (2009) 25: 748
- Jimenez-Garcia R, Hernandez-Barrera V, Jimenez-Trujillo I, Garrido PC, De Andres AL, De Miguel AG. Trends in cardiovascular risk factors and lifestyle behaviors among Spanish adults with diabetes (1993-2003). J Diabetes Complications (2009) 23: 394
- Laaban JP, Daenen S, Leger D, Pascal S, Bayon V, Slama G, Elgrably F. Prevalance and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab (2009) 35: 372
- Leeds JS, Forman EM, Morley S, Scott AR, Tesfaye S, Sanders DS. Abnormal liver function tests in patients with type 1 diabetes mellitus: Prevalence, clinical correlations and underlying pathologies. Diabet Med (2009) 26: 1235
- Mukai N, Doi Y, Ninomiya T, Hata J, Yonemoto K, Iwase M, Ida M, Kiyohara Y. Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: The Hisayama study. Diabetes Care (2009) 32: 2288
- Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G, Meisinger C. Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med (2009) 26: 1212
- Soria MLB, Sy RG, Vega BS, Ty-Willing T, Abenir-Gailardo A, Velandria F, Punzalan FE. The incidence of type 2 diabetes mellitus in the Philippines: A 9-year cohort study. Diabetes Res Clin Pract (2009) 86: 130
- Takeuchi T, Nakao M, Nomura K, Inoue M, Tsurugano S, Shinozaki Y, Yano E. Association of the metabolic syndrome with depression and anxiety in Japanese men: A 1-year cohort study. Diabetes Metab Res Rev (2009) 25: 762
- Taloyan M, Wajngot A, Johansson SE, Tovi J, Sundquist J. Cardiovascular risk factors in Assyrians/Syrians and native Swedes with type 2 diabetes: A population-based epidemiological study. Cardiovasc Diabetol (2009) 8: 59
- Urakami T, Suzuki J, Yoshida A, Saito H, Wada M, Takahashi S, Mugishima H. Prevalence of components of the metabolic syndrome in schoolchildren with newly diagnosed type 2 diabetes mellitus. Pediatr Diabetes (2009) 10: 508
- Wang H, Qiu Q, Tan LL, Liu T, Deng XQ, Chen YM, Chen W, Yu X, Hu BJ, Chen WQ. Prevalence and determinants of diabetes and impaired fasting glucose among urban community-dwelling adults in Guangzhou, China. Diabetes Metab (2009) 35: 378
- Yamamoto M, Yamaguchi T, Yamauchi M, Sugimoto T. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes. Diabetes Care (2009) 32: 2263
- Yang H, Wei Y, Gao X, Xu X, Fan L, He J, Hu Y, Liu X, Chen X, Yang Z, Zhang C. Risk factors for gestational diabetes mellitus in Chinese women—a prospective study of 16 286 pregnant women in China. Diabet Med (2009) 26: 1099
- Zhang SY, Tong WJ, Xu T, Wu B, Zhang YH. Diabetes and impaired fasting glucose in Mongolian population, Inner Mongolia, China. Diabetes Res Clin Pract (2009) 86: 124
- Zhou XH, Ji LN, Luo YY, Han XY, Zhang XY, Sun XQ, Ren Q, Qiao Q. Risk factors associated with the presence of diabetes in Chinese communities in Beijing. Diabetes Res Clin Pract (2009) 86: 233
- 5. Immunology
- Kocic GM, Kocic R, Pavlovic R, Jevtovic-Stoimenov T, Sokolovic D, Nikolic G, Pavlovic V, Stojanovic S, Basic J, Veljkovic A, Pavlovic D, Kamenov B. Possible impact of impaired double-stranded RNA degradation and nitrosative stress on immuno-inflammatory cascade in type 2 diabetes. Exp Clin Endocrinol Diabetes (2009) 117: 480
- Siljander HTA, Simell S, Hekkala A, Lahde J, Simell T, Vahasalo P, Veijola R, Ilonen J, Simell O, Knip M. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptability in the general population. Diabetes (2009) 58: 2835
- Simpson M, Mojibian M, Barriga K, Scott FW, Fasano A, Rewers M, Norris JM. An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr Diabetes (2009) 10: 563
- Tzellos TG, Tahmatzidis DK, Lallas A, Apostolidou K, Goulis DG. Pernicious anemia in a patient with type 1 diabetes mellitus and alopecia areata universalis. J Diabetes Complications (2009) 23: 434
- 6. Obesity
- Butler AE, Galasso R, Matveyenko A, Rizza RA, Dry S, Butler PC. Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia (2010) 53: 21
- Fatouros IG, Chatzinikolaou A, Tournis S, Nikolaidis MG, Jamurtas AZ, Douroudos II, Papassotiriou I, Thomakos PM, Taxildaris K, Mastorakos G, Mitrakou A. Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals. Diabetes Care (2009) 32: 2161
- Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality?. Diabetes Care (2009) 32: 2297
- Leehey DJ, Moinuddin I, Bast JP, Qureshi S, Jelinek CS, Cooper C, Edwards LC, Smith BM, Collins EG. Aerobic exercise in obese diabetic patients with chronic kidney disease: A randomized and controlled pilot study. Cardiovasc Diabetol (2009) 8: 62
- Liu BW, Lu Q, Ma CM, Wang SY, Lou DH, Lou XL, Yin FZ. Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes. Exp Clin Endocrinol Diabetes (2009) 117: 600
- Markowitz JT, Lowe MR, Volkening LK, Laffel LMB. Self-reported history of overweight and its relationship to disordered eating in adolescent girls with type 1 diabetes. Diabet Med (2009) 26: 1165
- Njajou OT, Kanaya AM, Holvoet P, Connelly S, Strotmeyer ES, Harris TB, Cummings SR, Hsueh WC. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes Metab Res Rev (2009) 25: 733
- Ong MJ, Guelfi KJ, Hunter T, Wallman KE, Fournier PA, Newnham JR. Supervised home-based exercise may attenuate the decline of glucose tolerance in obese pregnant women. Diabetes Metab (2009) 35: 418
- Turzyniecka M, Wild SH, Krentz AJ, Chipperfield AJ, Gamble J, Clough GF, Byrne CD. Skeletal muscle microvascular exchange capacity is associated with hyperglycaemia in subjects with central obesity. Diabet Med (2009) 26: 1112
- 7. Prediction and Prevention
- Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P, Parving HH. Telomere length predicts all-cause mortality in patients with type 1 diabetes. Diabetologia (2010) 53: 45
- Bell DSH, O'Keefe JH. Rediscovering bile acid sequestrants. Diabetes Obes Metab (2009) 11: 1114
- Berglund L, Berne C, Svardsudd K, Garmo H, Zethelius B. Early insulin response and insulin sensitivity are equally important as predictors of glucose tolerance after correction for measurement errors. Diabetes Res Clin Pract (2009) 86: 219
- Chen LW, Hu FB, Yeung E, Willett W, Zhang CL. Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of gestational diabetes mellitus. Diabetes Care (2009) 32: 2236
- Cox DJ, Ford D, Gonder-Frederick L, Clarke W, Mazze R, Weinger K, Ritterband L. Driving mishaps among individuals with type 1 diabetes: A prospective study. Diabetes Care (2009) 32: 2177
- Engberg S, Glumer C, Witte DR, Jorgensen T, Borch-Johnsen K. Differential relationship between physical activity and progression to diabetes by glucose tolerance status: The Inter99 Study. Diabetologia (2010) 53: 70
- Goldstein E, Hermann R, Renfors TJ, Nanto-Salonen KM, Korhonen T, Karkkainen M, Veijola RK, Knip M, Simell TT, Simell OG. From genetic risk awareness to overt type 1 diabetes: Parental stress in a placebo-controlled prevention trial. Diabetes Care (2009) 32: 2181
- Hoerger TJ, Zhang P, Segel JE, Gregg EW, Narayan KMV, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: Evidence and implications for remaining life expectancy. Diabetes Res Clin Pract (2009) 86: 225
- Li RL, O'Sullivan MJ, Robinson J, Safford MM, Curb D, Johnson KC. Family history of myocardial infarction predicts incident coronary heart disease in postmenopausal women with diabetes: The Women's Health Initiative Observational Study. Diabetes Metab Res Rev (2009) 25: 725
- Lin JW, Chang YC, Li HY, Chien YF, Wu MY, Tsai RY, Hsieh YC, Chen YJ, Hwang JJ, Chuang LM. Cross-sectional validation of diabetes risk scores for predicting diabetes, metabolic syndrome and chronic kidney disease in Taiwanese. Diabetes Care (2009) 32: 2294
- Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu LP, Palmer JP, Schatz D, Eisenbarth G. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care (2009) 32: 2269
- Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia (2010) 53: 268
- Salem M, El Behery S, Adly A, Khalil D, El Hadidi E. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes (2009) 10: 513
- So WY, Tong PC, Ko GT, Ma RC, Ozaki R, Kong AP, Yang XL, Ho CS, Lam CC, Chan JC. Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function. Diabetes Res Clin Pract (2009) 86: 89
- Vandemeulebroucke E, Keymeulen B, Decochez K, Weets I, De Block C, Fery F, Van de Velde U, Vermeulen I, De Pauw P, Mathieu C, Pipeleers DG, Gorus FK. Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients. Diabetologia (2010) 53: 36
- Vergouwe Y, Soedamah-Muthu SS, Zgibor J, Chaturvedi N, Forsblom C, Snell-Bergeon JK, Maahs DM, Groop PH, Rewers M, Orchard TJ, Fuller JH, Moons KG. Progression to microalbuminuria in type 1 diabetes: Development and validation of a prediction rule. Diabetologia (2010) 53: 254
- Villa-Caballero L, Arredondo EM, Campbell N, Elder JP. Family history of diabetes, parental body mass index predict obesity in Latino children. Diabetes Educ (2009) 35: 959
- 8. Intervention: b) Care
- Al-Ansari SA, Tennant MTS, Greve MDJ, Hinz BJ, Senior PA. Suboptimal diabetes care in high-risk diabetic patients attending a specialist retina clinic. Diabet Med (2009) 26: 1296
- Cavanaugh K, Wallston KA, Gebretsadik T, Shintani A, Huizinga MM, Davis D, Gregory RP, Malone R, Pignone M, DeWalt D, Elasy TA, Rothman RL. Addressing literacy and numeracy to improve diabetes care: Two randomized controlled trials. Diabetes Care (2009) 32: 2149
- Grant PS, Lipscomb D. How often do we ask about erectile dysfunction in the diabetes review clinic?. Acta Diabetol (2009) 46: 285
- Guthrie B, Emslie-Smith A, Morris AD. Which people with type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region. Diabet Med (2009) 26: 1269
- Ioacara S, Lichiardopol R, Ionescu-Tirgoviste C, Cheta D, Sabau S, Guja C, Farcasiu E, Tiu C. Improvements in life expectancy in type 1 diabetes patients in the last six decades. Diabetes Res Clin Pract (2009) 86: 146
- Jarvis J, Skinner TC, Carey ME, Davies MJ. How can structured self-management patient education improve outcomes in people with type 2 diabetes?. Diabetes Obes Metab (2010) 12: 12
- Kim MT, Han HR, Song HJ, Lee JE, Kim J, Ryu JP, Kim KB. A community-based, culturally tailored behavioral intervention for Korean Americans with type 2 diabetes. Diabetes Educ (2009) 35: 986
- McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, Kokoszka A, Matthews D, Pibernik-Okanovic M, Rodriguez-Saldana J, De Wit M, Snoek FJ. Short-form measures of diabetes-related emotional distress: The Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia (2010) 53: 66
- Murrock CJ, Higgins PA, Killion C. Dance and peer support to improve diabetes outcomes in African American women. Diabetes Educ (2009) 35: 995
- Parent KB, Wodrich DL, Hasan KS. Type 1 diabetes mellitus and school: A comparison of patients and healthy siblings. Pediatr Diabetes (2009) 10: 554
- Parkin CG, Hinnen D, Campbell RK, Geil P, Tetrick DL, Polonsky WH. Effective use of paired testing in type 2 diabetes: Practical applications in clinical practice. Diabetes Educ (2009) 35: 915
- Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: An update. Diabetes Technol Ther (2009) 11: 775
- Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther (2009) 11: 717
- Ruddock S, Fosbury J, Smith A, Meadows K, Crown A. Measuring psychological morbidity for diabetes commissioning. A cross-sectional survey of patients attending a secondary care diabetes clinic. Pract Diabetes Int (2010) 27: 22
10.1002/pdi.1434 Google Scholar
- Stern Z, Calderon-Margalit R, Mazar M, Brezis M, Tirosh A. Emergency room visit: A red-flag indicator for poor diabetes care. Diabet Med (2009) 26: 1105
- Thabit H, Kennelly SM, Bhagarva A, Ogunlewe M, McCormack PME, McDermott JH, Sreenan S. Utilization of Frontal Assessment Battery and Executive Interview 25 in assessing for dysexecutive syndrome and its association with diabetes self-care in elderly patients with type 2 diabetes mellitus. Diabetes Res Clin Pract (2009) 86: 208
- Wagner J, Allen NA, Swalley LM, Melkus GD, Whittemore R. Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes. Diabetes Res Clin Pract (2009) 86: 96
- Wagner JA, Perkins DW, Piette JD, Lipton B, Aikens JE. Racial differences in the discussion and treatment of depressive symptoms accompanying type 2 diabetes. Diabetes Res Clin Pract (2009) 86: 111
- Yuen HK, Wolf BJ, Bandyopadhyay D, Magruder KM, Salinas CF, London SD. Oral health knowledge and behavior among adults with diabetes. Diabetes Res Clin Pract (2009) 86: 239
- Zhang CX, Tse LA, Ye XQ, Lin FY, Chen YM, Chen WQ. Moderating effects of coping styles on anxiety and depressive symptoms caused by psychological stress in Chinese patients with type 2 diabetes. Diabet Med (2009) 26: 1282
- c) Drug Therapy
- Abidov M, Ramazanov Z, Seifulla R, Grachev S. The effect of Xanthigen™ in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes Metab (2010) 12: 72
- Brixner DI, McAdam-Marx C, Ye X, Boye KS, Nielsen LL, Wintle M, Misurski D, Fabunmi R. Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting. Diabetes Obes Metab (2009) 11: 1122
- Calvin AD, Aggarwal NR, Murad MH, Shi Q, Elamin MB, Geske JB, Fernandez-Balsells MM, Albuquerque FN, Lampropulos JF, Erwin PJ, Smith SA, Montori VM. Aspirin for the primary prevention of cardiovascular events: A systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care (2009) 32: 2300
- Chong AY, Lupsa BC, Cochran EK, Gorden P. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia (2010) 53: 27
- Davies MJ, Donnelly R, Barnett AH, Jones S, Nicolay C, Kilcoyne A. Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: Results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study. Diabetes Obes Metab (2009) 11: 1153
- De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P. Impact of the PPAR-γ2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: Evidence from BENEDICT. Diabetes (2009) 58: 2920
- Derosa G, Tinelli C, Maffioli P. Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes. Diabetes Obes Metab (2009) 11: 1091
- Echeverry D, Duran P, Bonds C, Lee M, Davidson MB. Effect of pharmacological treatment of depression on A1C and quality of life in low-income hispanics and African Americans with diabetes: A randomized, double-blind, placebo-controlled trial. Diabetes Care (2009) 32: 2156
- Everett J, Kerr D. Telehealth as adjunctive therapy in insulin pump treated patients: A pilot study. Pract Diabetes Int (2010) 27: 9
10.1002/pdi.1430 Google Scholar
- Fontbonne A, Diouf I, Baccara-Dinet M, Eschwege E, Charles MA. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: A post-hoc analysis of the BIGPRO1 trial. Diabetes Metab (2009) 35: 385
- Gallwitz B, Haring HU. Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureas. Diabetes Obes Metab (2010) 12: 1
- Gamble JM, Simpson SH, Eurich DT, Majumdar SR, Johnson JA. Insulin use and increased risk of mortality in type 2 diabetes: A cohort study. Diabetes Obes Metab (2010) 12: 47
- Gonzalez-Ortiz M, Guerrero-Romero JF, Violante-Ortiz R, Wacher-Rodarte N, Martinez-Abundis E, Aguilar-Salinas C, Islas-Andrade S, Arechavaleta-Granell R, Gonzalez-Canudas J, Rodriguez-Moran M, Zavala-Suarez E, Ramos-Zavala MG, Metha R, Revilla-Monsalve C, Beltran-Jaramillo TJ. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus. J Diabetes Complications (2009) 23: 376
- Jendle J, Nauck MA, Matthews DR, Frid A, Hermansen K, During M, Zdravkovic M, Strauss BJ, Garber AJ. Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Obes Metab (2009) 11: 1163
- Kapitza C, Heise T, Birman P, Jallet K, Ramis J, Balena R. Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with type 2 diabetes. Diabet Med (2009) 26: 1156
- Kato T, Sawai Y, Kanayama H, Taguchi H, Terabayashi T, Taki F, Yamada K, Yamazaki Y, Hayakawa N, Suzuki A, Oda N, Katada N, Itoh M. Comparative study of low-dose pioglitazone or metformin treatment in Japanese diabetic patients with metabolic syndrome. Exp Clin Endocrinol Diabetes (2009) 117: 593
- Kazda C, Gallwitz B, Simo R, Guzman JR, Kraus P, Nicolay C, Rose L, Schernthaner G. The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: Rationale and patient characteristics. Diabetes Obes Metab (2009) 11: 1131
- Khalangot M, Tronko M, Krauchenko V, Kovtun V. Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study. Diabetes Res Clin Pract (2009) 86: 247
- Khamseh ME, Safarnejad B, Baradaran HR. The effect of captopril on progression of retinopathy in type 2 diabetes. Diabetes Technol Ther (2009) 11: 711
- Khoo EYH, Wallis J, Tsintzas K, Macdonald IA, Mansell P. Effects of exenatide on circulating glucose, insulin, glucagon, cortisol and catecholamines in healthy volunteers during exercise. Diabetologia (2010) 53: 139
- Leung WY, So WY, Stewart D, Lui A, Tong PC, Ko GT, Kong AP, Ma RC, Chan FK, Yang XL, Chiang SC, Chan JC. Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - A longitudinal observational study. Cardiovasc Diabetol (2009) 8: 57
- Li CJ, Xia JL, Zhang GK, Wang SZ, Wang L. Nateglinide versus repaglinide for type 2 diabetes mellitus in China. Acta Diabetol (2009) 46: 325
- Lowe JM, Mensch M, McElduff P, Fitzgerald M, Attia J. Does an advanced insulin education programme improve outcomes and health service use for people with type 2 diabetes? A 5-year follow-up of the Newcastle Empowerment course. Diabet Med (2009) 26: 1277
- Luzio SD, Dunseath G, Lockett A, Broke-Smith TP, New RR, Owens DR. The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes. Diabetes Obes Metab (2010) 12: 82
- Marrett E, Stargardt T, Mavros P, Alexander CM. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: Associations with hypoglycaemia and weight gain. Diabetes Obes Metab (2009) 11: 1138
- Mathews EH, Pelzer R. A new model to estimate bolus insulin need. Diabetes Technol Ther (2009) 11: 813
- McAdam-Marx C, Ye X, Brixner DI, Fabunmi R, Wintle M, Boye KS, Misurski D, Nielsen LL. A1C and weight outcomes at 18 months in patients with type 2 diabetes treated with exenatide in an ambulatory care setting. Diabetes Obes Metab (2009) 11: 1173
- McAdam-Marx C, Bouchard J, Aagren M, Nelson R, Brixner D. Analysis of glycaemic control and weight change in patients initiated with human or analog insulin in an US ambulatory care setting. Diabetes Obes Metab (2010) 12: 54
- Monami M, Lamanna C, Balzi D, Marchionni N, Mannucci E. Sulphonylureas and cancer: A case-control study. Acta Diabetol (2009) 46: 279
- Rabbone I, Scaramuzza A, Bobbio A, Bonfanti R, Iafusco D, Lombardo F, Toni S, Tumini S, Cerutti F. Insulin pump therapy management in very young children with type 1 diabetes using continuous subcutaneous insulin infusion. Diabetes Technol Ther (2009) 11: 707
- Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes the RealTrend study. Diabetes Care (2009) 32: 2245
- Retnakaran R, Yakubovich N, Qi Y, Opsteen C, Zinman B. The response to short-term intensive insulin therapy in type 2 diabetes. Diabetes Obes Metab (2010) 12: 65
- Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL, Katayama S, Ito S, Mimran A, Menne J, Rump LC, Januszewicz A, Haller H. Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2010) 53: 49
- Rodbard D, Jovanovic L, Garg SK. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther (2009) 11: 757
- Rosenstock J, Rendell MS, Gross JL, Fleck PR, Wilson CA, Mekki Q. Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia. Diabetes Obes Metab (2009) 11: 1145
- Rosenstock J, Cefalu WT, Hollander PA, Klioze SS, Reis J, Duggan WT. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: A 3-year randomized controlled trial. Diabetes Technol Ther (2009) 11: 697
- Rother KI, Spain LM, Wesley RA, Digon BJ, Baron A, Chen K, Nelson P, Dosch HM, Palmer JP, Brooks-Worrell B, Ring M, Harlan DM. Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes. Diabetes Care (2009) 32: 2251
- Rubin RR, Peyrot M, Kruger DF, Travis LB. Barriers to insulin injection therapy patient and health care provider perspectives. Diabetes Educ (2009) 35: 1014
- Saitoh Y, Hongwei W, Ueno H, Mizuto M, Nakazato M. Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells. Diabetes Metab (2009) 35: 392
- Salti I. Efficacy and safety of insulin glargine and glimepiride in subjects with type 2 diabetes before, during and after the period of fasting in Ramadan. Diabet Med (2009) 26: 1255
- Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B. Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18). Diabet Med (2009) 26: 1242
- Shane-McWhorter L, Armor B, Johnson JT, Letassy N, Reichert SL, Sisson EM, Hanson JBS, Triplett C, Vivian EM. Pharmacist scope of practice, standards of practice and standards of professional performance for diabetes educators. Diabetes Educ (2009) 35: 69S
- Shashaj B, Sulli N. Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment. Diabetes Technol Ther (2009) 11: 767
- Sobngwi E, Lekoubou AL, Dehayem MY, Nouthe BE, Balti EV, Nwatsock F, Akwo EA, Effoe VS, Balla VT, Mamdjokam AS, Siaha V, Tabi CA, Mvom A, Djam I, Mbanya JC. Evaluation of a simple management protocol for hyperglycaemic crises using intramuscular insulin in a resource-limited setting. Diabetes Metab (2009) 35: 404
- Sudhakaran C, Anjana RM, Rao K, Unnikrishnan R, Suresh T, Mohan V. Role of continuous subcutaneous insulin infusion in patients with recalcitrant diabetes in south India. Diabetes Technol Ther (2009) 11: 733
- Swinnen SGHA, Snoek FJ, Dain MP, DeVries JH, Hoekstra JBL, Holleman F. Rationale, design and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes. Diabetes Technol Ther (2009) 11: 739
- Szewieczek J, Dulawa J, Strzalkowska D, Batko-Szwaczka A, Hornik B. Normal insulin response to short-term intense exercise is abolished in type 2 diabetic patients treated with gliclazide. J Diabetes Complications (2009) 23: 380
- Van Gaal LF, Caterson ID, Coutinho W, Finer N, Maggioni AP, Sharma AM, Torp-Pedersen C, Ge H, Moran SA, Shepherd GM, James WP. Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: An analysis from the 6-week lead-in period of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab (2010) 12: 26
- Wolffenbuttel BHR, Klaff LJ, Bhushan R, Fahrbach JL, Jiang H, Martin S. Initiating insulin therapy in elderly patients with type 2 diabetes: Efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents. Diabet Med (2009) 26: 1147
- d)Economics
- Bowser DM, Utz S, Glick D, Harmon R, Rovnyak V. The relationship between diabetes mellitus, depression and missed appointments in a low-income uninsured population. Diabetes Educ (2009) 35: 966
- Coeli CM, Faerstein E, Chor D, Lopes CS, Werneck GL. Gender differences in the socioeconomic gradient in self-reported diabetes: Does health service access play a role?. Diabetes Res Clin Pract (2009) 86: 134
- Fu AZ, Qiu Y, Radican L, Wells BJ. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care (2009) 32: 2187
- Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the US. Diabetes Care (2009) 32: 2225
- Kurlander JE, Kerr EA, Krein S, Heisler M, Piette JD. Cost-related nonadherence to medications among patients with diabetes and chronic pain factors beyond finances. Diabetes Care (2009) 32: 2143
- Liatis S, Thomakos P, Papaoikonomou S, Papazafeiropoulou A, Giannakopoulous N, Karagiaouri E, Sotiropoulos A, Bousboulas S, Melidonis A, Pappas S, Katsilambros N. Trends in the management of type 2 diabetes and its prescription drug costs in Greece (1998 & 2006). Exp Clin Endocrinol Diabetes (2009) 117: 505
- Tobin CT. Highlights from the salary survey of diabetes educators 2008. Diabetes Educ (2009) 35: 931
- g) Nutrition
- Bradley U, Spence M, Courtney CH, McKinley MC, Ennis CN, McCance DR, McEneny J, Bell PM, Young IS, Hunter SJ. Low-fat versus low-carbohydrate weight reduction diets effects on weight loss, insulin resistance, and cardiovascular risk: A randomized control trial. Diabetes (2009) 58: 2741
- Choi SE. Diet-specific family support and glucose control among Korean immigrants with type 2 diabetes. Diabetes Educ (2009) 35: 978
- De Natale C, Annuzzi G, Bozzetto L, Mazzarella R, Costabile G, Ciano O, Riccardi G, Rivellese AA. Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients. Diabetes Care (2009) 32: 2168
- Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, Dandona P. Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: Implications for insulin resistance. Diabetes Care (2009) 32: 2281
- Jovanovic L. Using meal-based self-monitoring blood glucose (SMBG) data to guide dietary recommendations in patients with diabetes. Diabetes Educ (2009) 35: 1023
- Kirkham S, Akilen R, Sharma S, Tsiami A. The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes Metab (2009) 11: 1100
- Lin CY, Lin YC, Kuo HK, Hwang JJ, Lin JL, Chen PC, Lin LY. Association among acrylamide, blood insulin and insulin resistance in adults. Diabetes Care (2009) 32: 2206
- Mehta SN, Haynie DL, Higgins LA, Bucey NN, Rovner AJ, Volkening LK, Nansel TR, Laffel LMB. Emphasis on carbohydrates may negatively influence dietary patterns in youth with type 1 diabetes. Diabetes Care (2009) 32: 2174
- Perichart-Perera O, Balas-Nakash M, Parra-Covarrubias A, Rodriguez-Cano A, Ramirez-Torres A, Ortega-Gonzalez C, Vadillo-Ortega F. A medical nutrition therapy program improves perinatal outcomes in Mexican pregnant women with gestational diabetes and type 2 diabetes mellitus. Diabetes Educ (2009) 35: 1004
- Sun S, Puttha R, Ghezaiel S, Skae M, Cooper C, Amin R. The effect of biopsy-positive silent coeliac disease and treatment with a gluten-free diet on growth and glycaemic control in children with type 1 diabetes. Diabet Med (2009) 26: 1250
- h) Surgery
- Icks A, Haastert B, Trautner C, Giani G, Glaeske G, Hoffmann F. Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population. Findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes (2009) 117: 500
- Kumar KVSH, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, Modi KD. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther (2009) 11: 785
- Rodriguez L, Reyes E, Fagalde P, Oltra MS, Saba J, Aylwin CG, Prieto C, Ramos A, Galvao M, Gersin KS, Sorli C. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther (2009) 11: 725
- i) Transplantation
- Ishida-Oku M, Iwase M, Sugitani A, Masutani K, Kitada H, Tanaka M, Iida M. A case of recurrent type 1 diabetes mellitus with insulitis of transplanted pancreas in simultaneous pancreas-kidney transplantation from cardiac death donor. Diabetologia (2010) 53: 341
- 9. Pathology and Complications: b) Cardiovascular
- Barchetta I, Sperduti L, Germano G, Valiante S, Vestri A, Fraioli A, Baroni MG, Cavallo MG. Subclinical vascular alterations in young adults with type 1 diabetes detected by arterial tonometry. Diabetes Metab Res Rev (2009) 25: 756
- Baris N, Erdogan M, Sezer E, Saygili F, Ozgonul AM, Turgan N, Ersoz B. Alterations in L-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria. Acta Diabetol (2009) 46: 309
- Buscemi S, Verga S, Batsis JA, Cottone S, Mattina A, Re A, Arnone M, Citarda S, Cerasola G. Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome. Diabetes Res Clin Pract (2009) 86: 177
- Dinh W, Futh R, Nickl W, Krahn T, Ellinghaus P, Scheffold T, Bansemir L, Bufe A, Barroso MC, Lankisch M. Elevated plasma levels of TNF-α and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol (2009) 8: 58
- Futh R, Dinh W, Bansemir L, Ziegler G, Bufe A, Wolfertz J, Scheffold T, Lankisch M. Newly detected glucose disturbance is associated with a high prevalance of diastolic dysfunction: Double risk for the development of heart failure?. Acta Diabetol (2009) 46: 335
- Gul A, Rahman MA, Hasnain SN. Influence of fructose concentration on myocardial infarction in senile diabetic and non-diabetic patients. Exp Clin Endocrinol Diabetes (2009) 117: 605
- Hamed S, Brenner B, Aharon A, Daoud D, Roguin A. Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus. Cardiovasc Diabetol (2009) 8: 56
- Isogawa A, Yamakado M, Yano M, Shiba T. Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness. Diabetes Res Clin Pract (2009) 86: 213
- McLellan K, Petrofsky JS, Zimmerman G, Lohman E, Prowse M, Schwab E, Lee S. The influence of environmental temperature on the response of the skin to local pressure: The impact of aging and diabetes. Diabetes Technol Ther (2009) 11: 791
- Miki T, Miura T, Hotta H, Tanno M, Yano T, Sato T, Terashima Y, Takada A, Ishikawa S, Shimamoto K. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3β-mediated suppression of mitochondrial permeability transition. Diabetes (2009) 58: 2863
- Muzaffar TH, Muzaffar FJ. A rare complication of diabetes mellitus in a 65-year-old man. J Diabetes Complications (2009) 23: 438
- Nathanson D, Zethelius B, Berne C, Holst JJ, Sjoholm A, Nystrom T. Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease. Diabetologia (2010) 53: 277
- Osawa H, Doi Y, Makino H, Ninomiya T, Yonemoto K, Kawamura R, Hata J, Tanizaki Y, Iida M, Kiyohara Y. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: The Hisayama study. Cardiovasc Diabetol (2009) 8: 60
- Pratte KA, Baron AE, Ogden LG, Hassell KL, Rewers M, Hokanson JE. Plasminogen activator inhibitor-1 is associated with coronary artery calcium in type 1 diabetes. J Diabetes Complications (2009) 23: 387
- c) Eye disease
- Chen JL, Luviano DM, Chen JC, Yu F, Sarraf D. Comparison of diabetic retinopathy phenotype between Latinos and Blacks. J Diabetes Complications (2009) 23: 371
- Nagi DK, Gosden C, Walton C, Winocour PH, Turner B, Williams R, James J, Holt RIG. A national survey of the current state of screening services for diabetic retinopathy: ABCD-Diabetes UK survey of specialist diabetes services 2006. Diabet Med (2009) 26: 1301
- Wong TY, Mwamburi M, Klein R, Larsen M, Flynn H, Hernandez-Medina M, Ranganathan G, Wirostko B, Pleil A, Mitchell P. Rates of progression in diabetic retinopathy during different time periods: A systematic review and meta-analysis. Diabetes Care (2009) 32: 2307
- d) Gestational and fetal
- Anderson JM, Savvidou MD, Kaihura C, McEniery CM, Nicolaides KH. Maternal arterial stiffness in pregnancies affected by type 1 diabetes mellitus. Diabet Med (2009) 26: 1135
- D'Anna R, Baviera G, Corrado F, Giordano D, Recupero S, Di Benedetto A. First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes. Diabet Med (2009) 26: 1293
- Kerenyi Z, Gyula T, Kivimaki M, Peterfalvi A, Madarasz E, Bosnyak Z, Tabak AG. Maternal glycemia and risk of large-for-gestational-age babies in a population-based screening. Diabetes Care (2009) 32: 2200
- Kim C. Managing women with gestational diabetes mellitus in the postnatal period. Diabetes Obes Metab (2010) 12: 20
- Kwong S, Mitchell RS, Senior PA, Chik CL. Postpartum diabetes screening adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care (2009) 32: 2242
- Lawlor DA, Fraser A, Lindsay RS, Ness A, Dabelea D, Catalano P, Smith GD, Sattar N, Nelson SM. Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: Findings from a prospective pregnancy cohort. Diabetologia (2010) 53: 89
- Telejko B, Zonenberg A, Kuzmicki M, Modzelewska A, Niedziolko-Bagniuk K, Ponurkiewicz A, Nikolajuk A, Gorska M. Circulating asymmetric dimethylarginine, endothelin-1 and cell adhesion molecules in women with gestational diabetes. Acta Diabetol (2009) 46: 303
- Wilson N, Ashawesh K, Padinjakara RNK, Anwar A. The multidisciplinary diabetes-endocrinology clinic and postprandial blood glucose monitoring in the management of gestational diabetes: Impact on maternal and neonatal outcomes. Exp Clin Endocrinol Diabetes (2009) 117: 486
- e) Neurological
- Al-Hajeri T, El-Gebely S, Abdella N. Profound weight loss in a type 2 diabetic patient with diabetic neuropathic cachexia: A case report. Diabetes Metab (2009) 35: 422
- Carlotti APCP, St George-Hyslop C, Guerguerian AM, Bohn D, Kamel KS, Halperin ML. Occult risk factor for the development of cerebral edema in children with diabetic ketoacidosis: Possible role for stomach emptying. Pediatr Diabetes (2009) 10: 522
- Duran-Jimenez B, Dobler D, Moffatt S, Rabbabi N, Streuli CH, Thornalley PJ, Tomlinson DR, Gardiner NJ. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes (2009) 58: 2893
- Glaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: Could cerebral ischemia and reperfusion injury be involved?. Pediatr Diabetes (2009) 10: 534
- Greco D, Gambina F, Pisciotta M, Abrignani M, Maggio F. Clinical characteristics and associated comorbidities in diabetic patients with restless legs syndrome. Exp Clin Endocrinol Diabetes (2009) 117: 496
- Kim HC, Cho YJ, Ahn CW, Park KS, Kim JC, Nam JS, Im YS, Lee JE, Lee SC, Lee HK. Nerve growth factor and expression of its receptors in patients with diabetic neuropathy. Diabet Med (2009) 26: 1228
- Papanas N, Courcoutsakis N, Papatheodorou K, Daskalogiannakis G, Maltezos E, Prasopoulos P. Achilles tendon volume in type 2 diabetic patients with or without peripheral neuropathy: MRI study. Exp Clin Endocrinol Diabetes (2009) 117: 645
- Thomsen NOB, Englund E, Thrainsdottir S, Rosen I, Dahlin LB. Intraepidermal nerve fibre density at wrist level in diabetic and non-diabetic patients. Diabet Med (2009) 26: 1120
- Van den Berg E, Reijmer YD, De Bresser J, Kessels RPC, Kappelle LJ, Biessels GJ. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia (2010) 53: 58
- f) Podiatrical
- Iversen MM, Tell GS, Ruse T, Hanestad BR, Ostbye T, Graue M, Midthjell K. History of foot ulcer increases mortality among individuals with diabetes ten-year follow-up of the Nord-Trondelag Health study, Norway. Diabetes Care (2009) 32: 2193
- Owings TM, Apelqvist J, Stenstrom A, Becker M, Bus SA, Kalpen A, Ulbrecht JS, Cavanagh PR. Plantar pressures in diabetic patients with foot ulcers which have remained healed. Diabet Med (2009) 26: 1141
- Valabhji J, Oliver N, Samarasinghe D, Mali T, Gibbs RGJ, Gedroyc WMW. Conservative management of diabetic forefoot ulceration complicated by underlying osteomyelitis: The benefits of magnetic resonance imaging. Diabet Med (2009) 26: 1127
- g) Renal
- Costacou T, Ferrell RE, Ellis D, Orchard TJ. Haptoglobin genotype and renal function decline in type 1 diabetes. Diabetes (2009) 58: 2904
- Lin J, Hu FB, Mantzoros C, Curhan GC. Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes. Diabetologia (2010) 53: 263
- Zhu WW, Chen HP, Ge YC, Xie HL, Zeng CH, Li LS, Liu ZH. Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy. Diabetes Res Clin Pract (2009) 86: 199
- 10. Endocrinology & Metabolism
- Alibegovic AC, Hojbjerre L, Sonne MP, Van Hall G, Stallknect B, Dela F, Vaag A. Impact of 9 days of bed rest on hepatic and peripheral insulin action, insulin secretion, and whole-body lipolysis in health young male offspring of patients with type 2 diabetes. Diabetes (2009) 58: 2749
- Bartoli E, Castello L, Sainaghi PP, Bergamasco L. Quantitative assessment of the abnormalities of hyperosmolar coma when glucose excess is larger than Na deficit. Exp Clin Endocrinol Diabetes (2009) 117: 587
- Brown RJ, Walter M, Rother KI. Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care (2009) 32: 2184
- Cnop M, Hughes SJ, Igoillo-Esteve M, Hoppa MB, Sayyed F, Van de Laar L, Gunter JH, De Koning EJP, Walls GV, Gray DWG, Johnson PR, Hansen BC, Morris JF, Pipeleers-Marichal M, Cnop I, Clark A. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia (2010) 53: 321
- Cooperberg BA, Cryer PE. Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans. Diabetes Care (2009) 32: 2275
- Cunha DA, Ladriere L, Ortis F, Igoillo-Esteve M, Gurzov EN, Lupi R, Marchetti P, Eizirik DL, Cnop M. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes (2009) 58: 2851
- Edgerton DS, Ramnanan CJ, Grueter CA, Johnson KMS, Lautz M, Neal DW, Williams PE, Cherrington AD. Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo. Diabetes (2009) 58: 2766
- Gimenez M, Lara M, Jimenez A, Conget I. Glycaemic profile characteristics and frequency of impaired awareness of hypoglycaemia in subjects with T1D and repeated hypoglycaemic events. Acta Diabetol (2009) 46: 291
- Grossin N, Wautier MPS, Picot J, Stern DM, Wautier JLT. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms. Diabetes Metab (2009) 35: 410
- Hojman P, Pedersen M, Nielsen AR, Krogh-Madsen R, Yfanti C, Akerstrom T, Nielsen S, Pedersen BK. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes (2009) 58: 2797
- Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev (2009) 25: 768
- Ikemoto T, Hosoya T, Takata K, Aoyama H, Hiramatsu T, Onoe H, Suzuki M, Endo M. Functional role of neuroendocrine-specific protein-like 1 in membrane translocation of GLUT4. Diabetes (2009) 58: 2802
- Lim A, Park SH, Sohn JW, Jeon JH, Park JH, Song DK, Lee SH, Ho WK. Glucose deprivation regulates KATP channel trafficking via, AMP-activated protein kinase in pancreatic beta-cells. Diabetes (2009) 58: 2813
- McLaughlin T, Deng A, Yee G, Lamendola C, Reaven G, Tsao PS, Cushman SW, Sherman A. Inflammation in subcutaneous adipose tissue: Relationship to adipose cell size. Diabetologia (2010) 53: 369
- Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, Yamahara K, Taura D, Inuzuka M, Sonoyama T, Nakao K. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes (2009) 58: 2880
- Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Martini F, Scaglione GL, Speranza D, Santini S, Zuppi C, Ghirlanda G. Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus. Diabetes Res Clin Pract (2009) 86: 173
- Retnakaran R, Qi Y, Goran MI, Hamilton JK. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med (2009) 26: 1198
- Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, Arner P, Eckel J. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes (2009) 58: 2731
- Sonoki K, Iwase M, Sasaki N, Ohdo S, Higuchi S, Matsuyama N, Iida M. Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2 paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract (2009) 86: 117
- Wang JB, Guan J, Shen J, Zhou L, Zhang YJ, Si YF, Yang L, Jian XH, Sheng Y. Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus. Diabetes Res Clin Pract (2009) 86: 83
- 11. Experimental Studies
- Alam C, Valkonen S, Ohis S, Tornqvist K, Hanninen A. Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice. Diabetologia (2010) 53: 346
- Barrera JG, D'Alessio DA, Drucker DJ, Woods SC, Seeley RJ. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats. Diabetes (2009) 58: 2820
- Blankenhorn EP, Cort L, Greiner DL, Guberski DL, Mordes JP. Virus-induced autoimmune diabetes in the LEW.1WR1 rat requires Iddm14 and a genetic locus proximal to the major histocompatibility complex. Diabetes (2009) 58: 2930
- Cetinkalp S, Delen Y, Karadeniz M, Yuce G, Yilmaz C. The effect of 1α,25(OH)2D3 vitamin over oxidative stress and biochemical parameters in rats where type 1 diabetes is formed by streptozotocin. J Diabetes Complications (2009) 23: 401
- Chao LC, Wroblewski K, Zhang ZD, Pei LM, Vergnes L, Ilkayeva OR, Ding SY, Reue K, Watt MJ, Newgard CB, Pilch PF, Hevener AL, Tontonoz P. Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes (2009) 58: 2788
- Cornolti R, Cattaneo I, Trudu M, Figliuzzi M, Remuzzi A. Effect of islet transplantation on metabolic glucose control in rats with diabetes. Diabetes Technol Ther (2009) 11: 805
- Cosson E, Valensi P, Laude D, Mesangeau D, Dabire H. Arterial stiffness and the autonomic nervous system during the development of Zucker diabetic fatty rats. Diabetes Metab (2009) 35: 364
- Dong YF, Liu L, Kataoka K, Nakamura T, Fukuda M, Tokutomi Y, Nako H, Ogawa H, Kim-Mitsuyama S. Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Diabetologia (2010) 53: 180
- Dreja T, Jovanovic Z, Rasche A, Kluge R, Herwig R, Tung YCL, Joost HG, Yeo GSH, Al-Hasani H. Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndrome. Diabetologia (2010) 53: 309
- Edwards JL, Quattrini A, Lentz SI, Figueroa-Romero C, Cerri F, Backus C, Hong Y, Feldman EL. Diabetes regulates mitochondrial biogenesis and fission in mouse neurons. Diabetologia (2010) 53: 160
- Frigerio F, Brun T, Bartley C, Usardi A, Bosco D, Ravnskjaer K, Mandrup S, Maechler P. Peroxisome proliferator-activated receptor α (PPARα) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism. Diabetologia (2010) 53: 331
- Hashimoto H, Arai T, Mori A, Kawai K, Hikishima K, Ohnishi Y, Eto T, Ito M, Hioki K, Suzuki R, Ohsugi M, Saito M, Ueyama Y, Okano H, Yamauchi T, Kubota N, Ueki K, Tobe K, Tamaoki N, Kadowaki T, Kosaka K. Reconsideration of insulin signals induced by improved laboratory animal diets, Japanese and American diets, in IRS-2 deficient mice. Exp Clin Endocrinol Diabetes (2009) 117: 577
- Katsuta H, Akashi T, Katsuta R, Nagaya M, Kim D, Arinobu Y, Hara M, Bonner-Weir S, Sharma AJ, Akashi K, Weir GC. Single pancreatic beta cells co-express multiple islet hormone genes in mice. Diabetologia (2010) 53: 128
- Krutzfeldt J, Stoffel M. Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice. Diabetologia (2010) 53: 123
- Li J, Liu X, Ran X, Chen J, Li X, Wu W, Huang H, Huang H, Long Y, Liang J, Cheng J, Tian H. Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity. Diabetes Obes Metab (2010) 12: 35
- Li JH, Gautam D, Han SJ, Guettier JM, Cui YH, Lu HY, Deng CX, O'Hare J, Jou W, Gavrilova O, Buettner C, Wess J. Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice. Diabetes (2009) 58: 2776
- Macke C, Prenzler NK, Horn R, Brabant G, Nave H. Ghrelin treatment increases receptor-bound leptin in healthy and endotoxemic obese Lewis rats. Exp Clin Endocrinol Diabetes (2009) 117: 473
- Nachnani JS, Bulchandani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Quinn T, Weide L, Alba LM. Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia (2010) 53: 153
- Nyirenda MJ, Carter R, Tang JI, De Vries A, Schlumbohm C, Hillier SG, Streit F, Oellerich M, Armstrong VW, Fuchs E, Seckl JR. Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11β-hydroxysteroid dehydrogenase type 1. Diabetes (2009) 58: 2873
- Pham Y, Tu Y, Wu T, Allen TJ, Calkin AC, Watson AM, Li J, Jandeleit-Dahm KA, Toh BH, Cao Z, Cooper ME, Chai Z. Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis. Diabetologia (2010) 53: 170
- Prada PO, Ropelle ER, Mourao RH, De Souza CT, Pauli JR, Cintra DE, Schenka A, Rocco SA, Rittner R, Franchini KG, Vassallo J, Velloso LA, Carvalheira JB, Saad MJA. EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice. Diabetes (2009) 58: 2910
- Saisho Y, Butler AE, Manesso E, Galasso R, Zhang L, Gurlo T, Toffolo GM, Cobelli C, Kavanagh K, Wagner JD, Butler PC. Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys. Diabetologia (2010) 53: 111
- Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N, Behl Y, Alikhani M, Yang J, Braasch C, Graves DT. Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia (2010) 53: 378
- Tian J, Dang H, Von Beohmer H, Jaeckel E, Kaufman DL. Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens. Diabetes (2009) 58: 2843
- Toda C, Shiuchi T, Lee S, Yamaot-Esaki M, Fujino Y, Suzuki A, Okamoto S, Minokoshi Y. Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetes (2009) 58: 2757
- Utkan T, Yildiz F, Utkan NZ, Gacar N, Gocmez SS, Ulak G, Erden F, Sarioglu Y. Effects of diabetes and elevated glucose on nitrergic relaxations in the isolated duodenum of the rat. Acta Diabetol (2009) 46: 295
- Vetere A, Li WC, Paroni F, Juhl K, Guo L, Nishimura W, Dai X, Bonner-Weir S, Sharma A. OVO homologue-like 1 (Ovol1) transcription factor: A novel target of neurogenin-3 in rodent pancreas. Diabetologia (2010) 53: 115
- Watson AMD, Li J, Schumacher C, De Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KAM. The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice. Diabetologia (2010) 53: 192
- Yarkoni S, Kaminitz A, Sagiv Y, Askenasy N. Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. Diabetologia (2010) 53: 356
- Zhong LY, Yang ZH, Li XR, Wang H, Li L. Protective effects of melatonin against the damages of neuroendocrine-immune induced by lipopolysaccharide in diabetic rats. Exp Clin Endocrinol Diabetes (2009) 117: 463
- 12. Diagnosis and Techniques
- Bailey T, Zisser H, Chang A. New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time. Diabetes Technol Ther (2009) 11: 749
- Inoue K, Matsumoto M, Akimoto K. The threshold for definition of impaired fasting glucose in a Japanese population. Diabet Med (2009) 26: 1175
- Kamath A, Mahalingam A, Brauker J. Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor. Diabetes Technol Ther (2009) 11: 689
- Karon BS, Koch CD, Wockenfus AM, Brown JK. Accuracy of whole blood glucose measurement when venous catheter blood samples are used on glucose meters. Diabetes Technol Ther (2009) 11: 819
- Ozbek M, Erdogan M, Karadeniz M, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C, Tuzun M. Evaluation of beta cell dysfunction by mixed meal tolerance test and oral L-arginine in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2009) 117: 573
- Pawlowicz M, Birkholz D, Niedzwiecki M, Balcerska A. Difficulties or mistakes in diagnosing type 1 diabetes in children?—demographic factors influencing delayed diagnosis. Pediatr Diabetes (2009) 10: 542
- Pigeon E, Riou ME, St-Onge J, Couillard E, Tremblay A, Marette A, Weisnagel SJ, Joanisse DR. Validation of a simple index (SIisOGTT) of insulin sensitivity in a population of sedentary men. Diabetes Metab (2009) 35: 398
- Ryan MT, Savarese VW, Hipszer B, Dizdarevic I, Joseph M, Shively N, Joseph JI. Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients. Diabetes Technol Ther (2009) 11: 745
- Tura A, Sbrignadello S, Succurro E, Groop L, Sesti G, Pacini G. An empirical index of insulin sensitivity from short IVGTT: Validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia (2010) 53: 144
- Zhou XH, Ji LN, Luo YY, Zhang XY, Han XY, Qiao Q. Performance of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing. Diabet Med (2009) 26: 1262
